Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GLUTAMIC ACID HCL CAP 325MG 325 MG

GLUTAMIC ACID HYDROCHLORIDE : 325 MG · DIN 00179205 · STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.

Health Canada status: CANCELLED POST MARKET

What is GLUTAMIC ACID HCL CAP 325MG?

GLUTAMIC ACID HCL CAP 325MG 325 MG contains GLUTAMIC ACID HYDROCHLORIDE : 325 MG. It is listed in the Health Canada Drug Product Database under DIN 00179205, held by STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN00179205
Brand nameGLUTAMIC ACID HCL CAP 325MG
Generic / active ingredientGLUTAMIC ACID HYDROCHLORIDE : 325 MG
ManufacturerSTANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.
Strength325 MG
Dosage formCAPSULE
Route of administrationORAL
ScheduleEthical
ATC codeA09AB01 GLUTAMIC ACID HYDROCHLORIDE
AHFS class92:01.00* ; See footnote
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date31-Jul-2002
Original market date1957-12-31 00:00:00

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for GLUTAMIC ACID HCL CAP 325MG

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for GLUTAMIC ACID HCL CAP 325MG

Health Canada Drug Product Database (DPD), DIN 00179205. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.